The Massachusetts House passed a bill which aims to curb the use of step therapy by health insurers. Drugs that are designated with a “step therapy” condition of reimbursement are only paid for by ...

Publisher’s Note: This Health Affairs Blog post is part of a supported set of posts that will be published over the next few months. Health Affairs received support for the series from the American ...

GoodRx reports that step therapy requires patients to try lower-cost medications before coverage for prescribed treatments.

Step therapy, commonly referred to as ”fail first”, was designed to control costs by requiring patients to try lower-cost therapies before accessing the treatment originally prescribed. In theory, it ...

For many people living with psoriasis, finding a treatment that truly works can feel life-changing — clearer skin, fewer flares, and a sense of control. But before some people can access the most ...

For people with lupus, their relationship with their healthcare team is one of the most important aspects of managing their life with lupus. Step therapy imposes on that relationship in pursuit of ...

An opinion forum on recent news and major policy issues. Have a story suggestion? Let us know. For the third time in the past four years, the California Legislature considered a bill that would limit ...

For years, I’ve watched the barriers my patients face in accessing the treatments I prescribe continue to grow. That is part of the reason I and many other health care professionals and patients ...

Step therapy is when Medicare Part D plans ask beneficiaries to try a more affordable drug before approving higher-cost prescriptions. In Medicare, Part D covers general prescription drugs, whereas ...

Please provide your email address to receive an email when new articles are posted on . Despite a mounting number of state-level laws enacted to protect vulnerable patients against step therapy ...

After President Donald Trump announced last week that the federal government will begin negotiating with drug manufacturers for lower prices on medicines paid for by Medicare Part B, discussion has ...